OBJECTIVE: Preterm birth is the leading cause of perinatal morbidity and mortality. Vaginal progesterone and Arabin cervical pessary are both considered as preventive treatments in women at risk for preterm birth. However, there is little evidence as to which of these two interventions is the preferred management. The objective was to compare the rate of preterm delivery in pregnant women with a short cervical length managed with Arabin cervical pessary and vaginal progesterone versus vaginal progesterone alone STUDY DESIGN: This was a retrospective cohort study of singletons pregnancies managed in two tertiary medical centers between September 2011 and May 2017. One center utilized the combined treatment of Arabin cervical pessary and vaginal progesterone (study group) and the second utilized vaginal progesterone approach (control group). RESULTS: During the study period, a total of 202 pregnant women who underwent vaginal ultrasonography between 15-29 weeks gestation. They all had short cervical length ( 25 mm). Among them 94 (46.5%) and 108 (53.5%) patients were in the study and control group respectively. A significantly higher rate of patients in the study group had either a history of cervical incompetence (9.6% vs 0.9% respectively, P¼0.006) or cervical surgery (7.9% vs 0% respectively, P¼0.003). Despite having shorter cervical length at recruitment (14.3AE5.9 vs 16.9AE5.7 respectively, P¼0.002) the rate of spontaneous delivery<34 weeks gestation was lower in the study group (7.4% vs 17.6% respectively, P¼0.036) and they delivered one week later compared to the control group (37.2AE2.1 vs 36.2AE3.7 respectively, P¼0.02). CONCLUSION: We found that for pregnant women with singletons and who had a short cervical length, the combined treatment of Arabin cervical pessary and vaginal progesterone had lower rate of preterm delivery<34 weeks of gestation and prolonged gestation compared to those women who were treated with vaginal progesterone alone.
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338 How to define intrauterine-growth-restriction e based on sonographic growth curves or neonatal birthweight growth curves? OBJECTIVE: Intra-Uterine-Growth-Restriction (IUGR) is suspected when estimated fetal weight (EFW) <10 th percentile. Using a sonographic EFW growth curve (S-EFW) to diagnose IUGR has no known benefits. We aimed to assess the outcomes of pregnancies complicated with IUGR based on S-EFW in comparison to Appropriate for Gestational Age (AGA) and IUGR based solely on neonatal birthweight (BW) growth curves (N-BW) growth curves.
STUDY DESIGN: Retrospective study; computerized records in a single large university medical center. We included all women with singleton pregnancy and a sonographic EFW between 24-36 weeks who delivered at our center, 2010-2016. Each pregnancy was assigned to one of three groups based on the earliest EFW performed: G1-AGA, G2-IUGR based on S-EFW but not N-BW growth curves or G3-IUGR based solely on N-BW (figure).
Primary outcome was rate of BW<10 th percentile (SGA, small for gestational age). Secondary outcomes included rates of stillbirth, cesarean delivery, preterm delivery, NICU admission, Apgar<7 at 5 minutes and major congenital anomalies. Univariate analyses included Chi-square, one way ANOVA and Kruskal-Wallis tests. Multivariable logistic model controlling for confounders was used to assess the independent role of groups on primary outcome. All tests are two-sided. P value<0.05 was considered statistically significant. Analyses were carried out using SPSS software package version22 (IBM, Armonk, NY). RESULTS: 6005 women met inclusion criteria. Of those 5386 pregnancies (89.6%) were categorized as G1, 300 (5%) as G2 and 319 (5.3%) as G3. Maternal and pregnancies characteristics and outcomes are detailed in 
OBJECTIVE:
We hypothesized that women at high risk for SPTB receiving prenatal care (PNC) by a MFM specialist would have lower rates of PTB compared to those receiving standard obstetric PNC. STUDY DESIGN: A prospective, longitudinal cohort study of women with singleton, non-anomalous pregnancies at high risk for SPTB due to (1) history of !1 SPTB <37 weeks (2) cervical shortening <25mm or (3) hospitalization for acute preterm labor or PPROM, at a single academic institution between 2015-2018. Women receiving greater than 50% of their PNC with MFM were compared with those receiving PNC with other provider types, regardless of whether MFM provided inpatient hospitalization care. At our tertiary institution, the MFM group meets monthly to maintain and update PNC protocols on a publicly available website. Primary outcomes were PTB <37 weeks and major neonatal morbidity (diagnosis of necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia, or death before initial hospital discharge). We further stratified the analysis by a pregnancy history of !1 prior SPTB. Our secondary outcomes were PTB <34, 28, and 24 weeks' gestation. Data were analyzed by t-test, chi -2, and backwards stepwise logistic regression (where factors with p<0.10 remained in final models), and Kaplan-Meier survival curves. RESULTS: Between 2015 and 2018, 229 women met inclusion criteria; 127 (55.5%) with MFM care and 102 (44.5%) with standard OB care. Overall, 127 (55%) delivered preterm <37 weeks. Women receiving PNC with MFM delivered later compared to those with standard OB care (35.5 vs. 31.9 weeks, p<0.001). Rates of PTB <37 and <34 weeks were lower for all women and the subset with !1 prior PTB (Table 1) . Composite major neonatal morbidity was also lower among neonates whose mother received MFM care (9.5%) compared with standard care (20.6%), p¼0.017. In multivariable models adjusting for confounders, PNC with MFM was associated with a reduction in PTB <37 weeks for all women (aOR 0.21, 95% CI 0.11-0.41) and those with !1 prior PTB (aOR 0.30, 95% CI 0.14-0.65). Furthermore, these reductions were seen across gestational ages (Figure, Kaplan-Meier survival curve) . CONCLUSION: PNC provided by MFM providers with standardized counseling, management, and close surveillance was associated with significant pregnancy prolongation and lower major neonatal morbidity in women at high risk for SPTB. OBJECTIVE: Much attention is directed to the study of stillbirths due to the great burden of this devastating condition. However, data regarding risk factors and causality are still incomplete. Investigations into the specific contribution of each risk factor and their changes over time have not yet been fully addressed. The aim of this study was to identify the specific contribution of risk factors for stillbirth over time by observing the changes in odds ratios (ORs) throughout the years.
